demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 severe or critically
COVID-19 severe or critically
Immunostimulants drugs
convalescent plasma treatment CAPSID PICP19 ... AlQahtani Ray Li REMAP-CAP ... Rasheed RECOVER Pouladzadeh CP-COVID-19 O’Donnell ILBS-COVID-02 ... PlasmAr Sekine ...
immunoglobulin therapy Raman Tabarsi Gharebaghi
interferon
IFN beta-1a Davoudi-Monfared Kalil ... Darazam ...
IFN beta-1b Darazam ... Rahmani
neutralizing antibody
equine polyclonal antibodies INM005 Lopardo

6 studies excluded by filtering options 1

5406 Duan, 2020 1134not a RCThigh risk of bias
5446 Sean, 2020 1134not a RCThigh risk of bias
5549 Hegerova, 2020 1134not a RCThigh risk of bias
5761 Joyner, 2020 1313not a RCThigh risk of bias
6159 Gemici, 2020 0130selection pending
6940 Bihariesingh-Sanchit (SuriCovid), 2021 1310not a RCTrisk of bias not avaialble